FDA Approves Brainsway's TMS for Adolescent Depression

On November 13th, a breakthrough in mental health treatment for young people was announced. The FDA expanded the use of Brainsways Deep Transcranial Magnetic Stimulation system to treat major depressive disorder in adolescents aged 15-21. This approval, based on real-world evidence from over 1,100 adolescents, marks a significant step forward in mental health care, as it allows Brainsways system to reach the widest age range of any similar treatment for depression.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.